RGEN

REPLIGEN CORP

Life Sciences Tools & Services · Life Sciences Tools & Services

$158.34 sample

+2.79 (+1.79%) 1D

Market cap

$540.5B

Price as of

2026-10-04

Latest filing

8-K · 2026-08-14

Alerts

8

Price$158.34 +9.67% 3M daily closessample

158.34144.38

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider buy: General Counsel
Sep 17INSInsider sell: Chief Executive Officer
Sep 11INSInsider sell: General Counsel
Sep 03INSInsider sell: Chief Financial Officer
Aug 31INSInsider sell: EVP, Operations
Aug 21INSInsider buy: EVP, Operations
Aug 14SEC8-K filed: material event
Aug 10INSInsider sell: 10% owner

Sign up to see the real RGEN record →

Company facts

SEC EDGAR registration

Name: REPLIGEN CORP
Sector: Life Sciences Tools & Services
Industry: Life Sciences Tools & Services
Smart-money score: -30sample, -100 to +100
Reporting currency: USD

Who is positioning in RGEN

sample

Insiders: 7 insider transactions over 90 days, net selling, $11.7M
Congress: 1 members traded over 90 days
Institutions · 13F: 19 funds hold $8.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$18.5B +15.1% y/y

Q4 2024Q3 2026

Inventory$11.2B +17.6% y/y

Q4 2024Q3 2026

Accounts receivable$8.1B +14.4% y/y

Q4 2024Q3 2026

Total debt$22.0B +6.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $58.1B +2.2% 3M
Sample peer B: $228.1B -4.9% 3M
Sample peer C: $109.2B +15.3% 3M
Sample peer D: $208.8B +3.3% 3M
Sample peer E: $296.4B +3.5% 3M